The reiteration of a Buy rating and maintenance of a $22 price target by a reputable analyst like Joseph Stringer from Needham is likely to instill confidence among investors and could positively influence Stoke Therapeutics' stock price in the short term. The specific mention of the price target provides a clear benchmark for expectations, further supporting the potential for positive stock price movement.